DRW Securities LLC Has $4.22 Million Holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI)

DRW Securities LLC increased its holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 186.1% during the third quarter, HoldingsChannel reports. The fund owned 42,719 shares of the exchange traded fund’s stock after acquiring an additional 27,789 shares during the quarter. DRW Securities LLC’s holdings in SPDR S&P Biotech ETF were worth $4,221,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently made changes to their positions in XBI. Clal Insurance Enterprises Holdings Ltd bought a new stake in SPDR S&P Biotech ETF in the 3rd quarter worth about $141,284,000. Affinity Asset Advisors LLC grew its position in shares of SPDR S&P Biotech ETF by 105.4% during the 2nd quarter. Affinity Asset Advisors LLC now owns 37,550 shares of the exchange traded fund’s stock valued at $3,481,000 after acquiring an additional 737,550 shares during the period. Mirae Asset Securities USA Inc. bought a new position in shares of SPDR S&P Biotech ETF during the 2nd quarter valued at approximately $55,626,000. Assetmark Inc. increased its stake in shares of SPDR S&P Biotech ETF by 72,653.0% during the 3rd quarter. Assetmark Inc. now owns 589,299 shares of the exchange traded fund’s stock worth $58,223,000 after purchasing an additional 588,489 shares during the last quarter. Finally, Jane Street Group LLC raised its holdings in shares of SPDR S&P Biotech ETF by 68.7% in the 1st quarter. Jane Street Group LLC now owns 961,082 shares of the exchange traded fund’s stock worth $91,197,000 after purchasing an additional 391,333 shares during the period.

SPDR S&P Biotech ETF Trading Up 2.1 %

Shares of NYSEARCA XBI opened at $96.24 on Monday. The firm has a market cap of $7.34 billion, a price-to-earnings ratio of 11.47 and a beta of 1.11. The stock has a fifty day simple moving average of $98.44 and a two-hundred day simple moving average of $96.32. SPDR S&P Biotech ETF has a 1-year low of $71.99 and a 1-year high of $105.47.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.